Clinical Development
Complete Package for Clinical Trials
Whether your drug development journey started in early discovery or post-IND, WuXi AppTec offers sample analysis to support your clinical trials across all phases, ensuring a seamless progression from preclinical to clinical development.
Single Solution from Early to Late-Stage
When you engage WuXi AppTec as your drug development partner, you not only benefit from the multidisciplinary experience of our scientific teams, but also the continuous knowledge gained from working with your compound from start to finish. Our integrated approach enables us to become deeply familiar with the intricacies of your project and make informed, strategic decisions moving from preclinical through clinical trials.
Bioanalytical
- Small molecule and biologics quantitation
- Generic/biosimilar and innovator study support
- Biomarker testing
DMPK
- PK Met ID
- Mass Balance (hot & cold)
- CYP, Phase II enzyme and transporter substrate phenotyping
Toxicology
- Chronic and subchronic toxicology
- Seg I-III DART studies
- Carcinogenicity studies
- Juvenile toxicology
- 4-week batch impurity testing
Analytical Testing
- Late-phase commercial analytical development
- Stability studies
- Regulatory CMC
- Project management